In the published article, there was an error in the Funding statement. The funding universities request to add this exact sentence with no changes to grant numbers, only rephrasing the paragraph. This correction is required since this error is going to affect awards disposition at this University.
The correct Funding statement appears below.
Statements
Funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The authors extend their acknowledgement to Princess Nourah bint Abdulrahman University Researchers Supporting Project number (PNURSP2024R39), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia and Researchers Supporting Project number (RSPD2024R859), King Saud University, Riyadh, Saudi Arabia.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
Cryptosporidium, immunocompromised, eugenol, nitazoxanide, iNOS
Citation
Gattan HS, Wakid MH, Qahwaji RM, Altwaim S, Mahjoub HA, Alfaifi MS, Elshazly H, Al-Megrin WAI, Alshehri EA, Elshabrawy HA and El-kady AM (2024) Corrigendum: In silico and in vivo evaluation of the anti-cryptosporidial activity of eugenol. Front. Vet. Sci. 11:1407833. doi: 10.3389/fvets.2024.1407833
Received
27 March 2024
Accepted
22 April 2024
Published
08 May 2024
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
11 - 2024
Updates
Copyright
© 2024 Gattan, Wakid, Qahwaji, Altwaim, Mahjoub, Alfaifi, Elshazly, Al-Megrin, Alshehri, Elshabrawy and El-kady.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hatem A. Elshabrawy hatem.elshabrawy@shsu.eduAsmaa M. El-kady asmaa.elkady@med.svu.edu.eg
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.